Chemours Q2 Loss Narrows

August 04, 2026 — 05:26 pm EDT

Written by RTTNews.com for RTTNews

(RTTNews) - The Chemours Co. (CC) on Tuesday reported a narrower second-quarter net loss, while revenue edged down from last year as lower volumes partly offset pricing gains.

The company posted a net loss attributable to Chemours of $274 million or $1.81 per share, compared with a net loss of $380 million or $2.53 per share in the prior-year quarter. Adjusted net income declined to $64 million or $0.42 per share from $91 million or $0.61 per share a year ago.

Net sales slipped 1% to $1.591 billion from $1.615 billion last year. The decline reflected a 4% drop in volumes, partially offset by a 2% increase in pricing and a 1% currency tailwind.

For the third quarter, Chemours expects net sales to range from down 5% to flat sequentially and adjusted EBITDA of $175 million to $205 million.

The company reaffirmed its full-year 2026 outlook, projecting net sales growth of 1% to 5% and adjusted EBITDA of $775 million to $825 million.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Chemours Q2 Loss Narrows

Tags

Latest Articles